By Hope Hamilton To Southampton Arts Center Executive Director Christina Mossaides-Strassfield, Christine Mack is a ...

The artist is revisiting his roots and making special memories with his and Ricky Martin's twins Lucía and Renn ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

Does this mean it's time to dump your Moderna shares? First, it's important to note that Moderna's difficult times may not be over.

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Moderna Inc. has agreed to do a placebo-controlled trial of its new Covid vaccine that was recently approved by US regulators, Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday.

Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.

The Department of Health and Human Services (HHS) is canceling hundreds of millions of dollars in funding pledged to Moderna to help the company develop, test and license mRNA-based vaccines to com… ...

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

Moderna had been developing a vaccine to combat an outbreak of bird flu in dairy cattle in spring 2024, but the U.S. government is rescinding millions of dollars in funding.

Moderna, Inc. (NASDAQ: MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug Administration (FDA) for review of its updated COVID-19 vaccine.